up to now couple of years, the UK has witnessed a revolution in health-related fat‑decline treatments — from the introduction of semaglutide (Wegovy®) for the expanding attractiveness of tirzepatide (Mounjaro®). Now, An additional title is drawing consideration in both medical and public wellness